Surface modified hexagonal upconversion nanoparticles for the development of competitive assay for biodetection.

Padmaja Parameswaran Nampi1, Alexander Vakurov2, Sikha Saha3

  • 1School of Chemical and Process Engineering, Faculty of Engineering and Physical Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom; Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom.

Biomaterials Advances
|August 5, 2022
PubMed
Summary

Researchers developed up-conversion nanoparticles (UCNPs) for detecting the antibiotic ofloxacin. These modified nanoparticles form the basis of a sensitive and rapid photoluminescent nanobiosensor.

Related Concept Videos